Filter posts

Crowdfunding in Health Care and Biotechnology

Smaller private companies are constantly in search of capital, but many find it difficult to …

Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum

With 31 (and counting) life sciences companies having already placed IPOs on the market within …

Medicare Part B: Barriers to Cancer Treatment

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance …

How to Drive International Innovation: Scientific American Worldview

Which countries are winning the innovation game? Will the U.S. maintain its leadership position in …

Your Social Media Guide to #BIO2013

The BIO International Convention is the largest global event for the biotechnology industry; it attracts …

Small Biotech Companies and China: 5 Keys to Success

Big pharmaceutical countries aren’t the only ones investing in China. Emerging and mid-sized biotech companies are also …

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

The Presidential Inaugural: Looking Back at 30 Years of Biotech Policy Milestones

As President Barack Obama prepares for his second inauguration, we decided that it would be …

2012 Biotech Gift Guide

Welcome to this year’s BIOtechNOW Gift Guide, our most loved biotech gift ideas from 2012 …